Impact of stroma remodeling on forces experienced by cancer cells and stromal cells within a pancreatic tumor tissue

被引:0
|
作者
Connaughton, Morgan [1 ]
Dabagh, Mahsa [1 ]
机构
[1] Univ Wisconsin Milwaukee, Dept Biomed Engn, Milwaukee, WI 53211 USA
关键词
Pancreatic cancer; Remodeling; Stroma; ECM; Stresses within tumor; Cancer treatment; MECHANICAL-PROPERTIES; IN-VITRO; MICROENVIRONMENT; FIBROBLASTS; METASTASIS;
D O I
10.1186/s12938-024-01278-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Remodeling (re-engineering) of a tumor's stroma has been shown to improve the efficacy of anti-tumor therapies, without destroying the stroma. Even though it still remains unclear which stromal component/-s and what characteristics hinder the reach of nanoparticles deep into cancer cells, we hypothesis that mechanisms behind stroma's resistance to the penetration of nanoparticles rely heavily on extrinsic mechanical forces on stromal cells and cancer cells. Our hypothesis has been formulated on the basis of our previous study which has shown that changes in extracellular matrix (ECM) stiffness with tumor growth influence stresses exerted on fibroblasts and cancer cells, and that malignant cancer cells generate higher stresses on their stroma. This study attempts to establish a distinct identification of the components' remodeling on the distribution and magnitude of stress within a tumor tissue which ultimately will impact the resistance of stroma to treatment. In this study, our objective is to construct a three-dimensional in silico model of a pancreas tumor tissue consisting of cancer cells, stromal cells, and ECM to determine how stromal remodeling alters the stresses distribution and magnitude within the pancreas tumor tissue. Our results show that changes in mechanical properties of ECM significantly alter the magnitude and distribution of stresses within the pancreas tumor tissue. Our results revealed that these stresses are more sensitive to ECM properties as we see the stresses reaching to a maximum of 22,000 Pa for softer ECM with Young's modulus of 250 Pa. The stress distribution and magnitude within the pancreas tumor tissue does not show high sensitivity to the changes in mechanical properties of stromal cells surrounding stiffer cancer cells (PANC-1 with Young's modulus of 2400 Pa). However, softer cancer cells (MIA-PaCa-2 with (Young's modulus of 500 Pa) increase the stresses experienced by stiffer stromal cells and for stiffer ECM. By providing a unique platform to dissect and quantify the impact of individual stromal components on the stress distribution within a tumor tissue, this study serves as an important first step in understanding of which stromal components are vital for an efficient remodeling. This knowledge will be leveraged to overcome a tumor's resistance against the penetration of nanoparticles on a per-patient basis.
引用
下载
收藏
页数:19
相关论文
共 50 条
  • [41] CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer
    Kai Adachi
    Yasutaka Sakurai
    Masaaki Ichinoe
    Masayoshi Tadehara
    Akihiro Tamaki
    Yurika Kesen
    Takuya Kato
    Shinji Mii
    Atsushi Enomoto
    Masahide Takahashi
    Wasaburo Koizumi
    Yoshiki Murakumo
    Virchows Archiv, 2022, 480 : 819 - 829
  • [42] CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer
    Adachi, Kai
    Sakurai, Yasutaka
    Ichinoe, Masaaki
    Tadehara, Masayoshi
    Tamaki, Akihiro
    Kesen, Yurika
    Kato, Takuya
    Mii, Shinji
    Enomoto, Atsushi
    Takahashi, Masahide
    Koizumi, Wasaburo
    Murakumo, Yoshiki
    VIRCHOWS ARCHIV, 2022, 480 (04) : 819 - 829
  • [43] Antifibrotic Agent, Pirfenidone, Inhibits Pancreatic Stellate Cells and Tumor-Stromal Interaction in Pancreatic Cancer
    Kozono, S.
    Ohuchida, K.
    Eguchi, D.
    Fujiwara, K.
    Zhao, M.
    Cui, L.
    Mizumoto, K.
    Tanaka, M.
    PANCREAS, 2012, 41 (08) : 1377 - 1377
  • [44] Treatment of stromal tumor cells of pancreatic cancer improves therapeutic effect of TBH vaccination
    Moviglia, Gustavo
    Gaeta, Carlos
    Varela, Gabriela
    Iraola, Nora
    de Lima, Andrea Paes
    Costanzo, Hernan
    Farina, Pablo
    Avigliano, Andrea
    Bastos, Fabiana
    Schuster, Gustavo
    Ayala, Cesar
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 631 - 631
  • [45] Gene signatures from pancreatic cancer tumor and stromal cells predict disease outcome
    Filippos Kottakis
    Nabeel Bardeesy
    Nature Genetics, 2015, 47 : 1102 - 1103
  • [46] Gene signatures from pancreatic cancer tumor and stromal cells predict disease outcome
    Kottakis, Filippos
    Bardeesy, Nabeel
    NATURE GENETICS, 2015, 47 (10) : 1102 - 1103
  • [47] Effect of tumor-stromal cell interactions on drug sensitivity of pancreatic cancer cells
    Tatsuda, Daisuke
    Yoshida, Junjiro
    Ohishi, Tomokazu
    Kawada, Mnabu
    CANCER SCIENCE, 2018, 109 : 1147 - 1147
  • [48] Circulating tumor cells in pancreatic cancer: The prognostic impact in surgical patients
    Teja, Macarena
    Ocanto, Abrahams
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (08):
  • [49] Clinical impact of circulating tumor cells and therapy response in pancreatic cancer
    Okubo, K.
    Uenosono, Y.
    Arigami, T.
    Mataki, Y.
    Matsushita, D.
    Yanagita, S.
    Kurahara, H.
    Sakoda, M.
    Kijima, Y.
    Maemura, K.
    Natsugoe, S.
    EJSO, 2017, 43 (06): : 1050 - 1055
  • [50] Epithelial-stromal interactions in pancreatic cancer : Do pancreatic cancer cells actively recruit host stromal cells for their own benefit?
    Joshi, Swapna
    Qu, Changfa
    Phillips, Phoebe
    Kumar, Rakesh
    Pirola, Ron
    Wilson, Jeremy
    Goldstein, David
    Apte, Minoti
    CANCER RESEARCH, 2006, 66 (08)